NVO241220P90000
- 5.06
- 0.000.00%
Novo-Nordisk A/S Newsroom
Trending Stocks as Wall Street Bounces Back With Strong Week
Top Gap Ups and Downs on Friday: NVO, UBS, IBN and More
These Stocks Moved the Most Today: Apple, Alphabet, Qorvo, Novo Nordisk, SLB, J.B. Hunt, Rivian, and More -- Barrons.com
Novo-Nordisk A/S Options Spot-On: On January 17th, 93,932 Contracts Were Traded, With 417.48K Open Interest
Sector Update: Health Care Stocks Decline Late Afternoon
Novo Nordisk Unusual Options Activity
Sector Update: Health Care
Nvidia, Smucker, Muni Bonds, and 31 Other -6-
Hims & Hers Health Down 3% After BoA Says Q4 Revenue Could Be a Miss
European Equities Traded in the US as American Depositary Receipts Edge Higher Friday
EU Panel Starts Probe on Novo Nordisk Weight Loss Drugs' Links to Rare Eye Disease
Novo Nordisk's Positive Obesity Drug Data Insufficient to Buoy Shares -- Market Talk
Argus Research Maintains Novo-Nordisk A/S(NVO.US) With Buy Rating
4 Stocks to Watch on Friday: SLB, NVO and More
Novo Nordisk Shares Are Trading Lower After Ozempic Was Included in a List of 15 Medications for Medicare Drug Price Negotiations.
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Sector Update: Health Care Stocks Rise Premarket Friday
White House Says Popular Weight-loss Drug Ozempic Subject to Medicare Talks
These Stocks Are Moving the Most Today: Apple, Qorvo, Novo Nordisk, Fastenal, J.B. Hunt, Rivian, Salesforce, and More -- Barrons.com
Novo Nordisk's STEP UP Trial Shows Promising Results for Obesity Treatment